These healthcare giants have been top dividend stocks for years, and both could be intriguing options to consider right now.

It is also highly likely to be an important player in the industry where it competes. But that doesn't seem to matter today ...

Pfizer Inc. (NYSE:PFE) is one of the Most Undervalued US Stocks According to Hedge Funds. On May 13, Pfizer Inc. (NYSE:PFE) ...

In my March article, "Why Pfizer Remains A Strong Buy In 2026", I mainly discussed Pfizer's Q4 earnings ( PFE) and the ...

May 20 (Reuters) - Pfizer said on Wednesday its experimental pneumococcal vaccine showed significantly stronger immune response than its current shot, including up to 15-fold higher antibody levels ...

JNJ's diversified pharma and MedTech growth, pipeline progress and stronger 2026 outlook give it an edge over PFE.

As attorney general, Paxton has been fighting for MAHA causes such as pesticides, forever chemicals in clothing, food dyes, ...

LOE risks are mitigated by delayed Vyndamax generic entry to mid-2031, supporting the management’s high single-digit 5Y ...

The registrar ultimately concluded that the competing trademarks were “overall, dissimilar”. Read more at straitstimes.com.

A newly released federal document reveals that an internal Department of Health and Human Services (HHS) analysis linked ...

Pfizer Inc. said a new version of its bestselling Prevnar vaccine may provide infants with better protection against common ...

Pfizer's 25vPnC pneumococcal vaccine shows up to 15-fold higher antibody levels in infants, advancing to late-stage trials ...